See the difference! Customize Seeking Alpha:
Sign in or join
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Cypress Bioscience Inc. (CYPB)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: CYPB
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Analysis - Latest Articles
by
most recent
|
most commented
Cypress Bioscience: Investing in Pain
May 12, 2009
•
Richard Sater
•
1 Comment
FDA, Clinical Trial Calendar Updates: Actelion, Merck Discontinue Partnership
Apr 21, 2009
•
Mike Havrilla
•
10 Comments
Bullish Thesis for Biotech Remains Intact
Feb 5, 2009
•
Michael Becker
•
1 Comment
Looking for the Biotech Breakout
Jan 19, 2009
•
Jeff Pierce
•
5 Comments
Thursday Options Update: BAC, C, AAPL, CYPB & SQNM
Jan 15, 2009
•
Andrew Wilkinson
•
3 Comments
Trading FDA Decisions: Cypress Bioscience Soars, A Trio of Buys
Jan 15, 2009
•
Mike Havrilla
•
4 Comments
Stocks Affected by FDA Calendar of Expected Decision Dates
Jan 14, 2009
•
Mike Havrilla
•
Comment!
20 Emerging Healthcare Stocks to Watch in '09
Jan 11, 2009
•
Mike Havrilla
•
4 Comments
9 Possible Pharma Deals for 2009
Jan 8, 2009
•
Zacks.com
•
7 Comments
4 Drug Stocks Trading Above Moving Averages
Dec 31, 2008
•
Mike Havrilla
•
Comment!
3 Top and Bottom Market Sectors for This Week
Dec 30, 2008
•
J Clinton Hill
•
2 Comments
Two Calculated Risks Possibly Worth Taking
Dec 28, 2008
•
David White
•
31 Comments
Five Healthcare Stocks Positioned for a Happy New Year
Dec 23, 2008
•
Mike Havrilla
•
1 Comment
Updated FDA Calendar: Cypress Bioscience Looks Like a Buy
Dec 12, 2008
•
Mike Havrilla
•
1 Comment
Cytori Therapeutics and Cypress Bio: Two Buys Based on Positive Trial Results
Dec 9, 2008
•
Mike Havrilla
•
Comment!
AMAG, Caraco and More: Near-Term Catalysts, Courtesy FDA
Dec 3, 2008
•
Mike Havrilla
•
Comment!
Healthcare Stock Opportunities In a Down Market
Nov 22, 2008
•
Mike Havrilla
•
1 Comment
Hedge Fund Tracking: Lee Ainslie's Maverick Capital, Q3 2008
Nov 20, 2008
•
Market Folly
•
5 Comments
Backlog of Decisions Is Building at the FDA
Nov 8, 2008
•
Mike Havrilla
•
Comment!
60 Defensive Growth Stocks
Oct 26, 2008
•
Mike Havrilla
•
2 Comments
Six Healthcare Stocks at Sale Prices
Oct 26, 2008
•
Mike Havrilla
•
Comment!
FDA Action Before Year End
Oct 21, 2008
•
Mike Havrilla
•
Comment!
Potential Short Trades on Pending FDA Decisions
Oct 13, 2008
•
Mike Havrilla
•
4 Comments
Cypress Bioscience Could Be a Buy Given Upcoming FDA Decision
Oct 6, 2008
•
Mike Havrilla
•
1 Comment
Pharmaceuticals: Near Term Movers Based On FDA Decision Dates
Oct 6, 2008
•
Mike Havrilla
•
Comment!
FDA Fall Decision Calendar Features Some Likely Near-Term Movers
Sep 22, 2008
•
Mike Havrilla
•
2 Comments
Is Cypress Bioscience Poised to Move Ahead?
Sep 15, 2008
•
Mike Havrilla
•
Comment!
Cypress Bioscience: About To Reverse Course?
Aug 21, 2008
•
Badger The Lion
•
2 Comments
Monday Options Outlook: XME, EWZ, GDX, MVL, CYPB, MOT, BID
Aug 4, 2008
•
Andrew Wilkinson
•
Comment!
Cypress Bioscience Awaits Two Key Catalysts
Jul 13, 2008
•
Mike Havrilla
•
1 Comment
Loeb's Third Point Issues Latest 13F: Summary of Holdings
Aug 16, 2007
•
Lon Juricic
•
Comment!
Rob Black's Healthcare Market Roundup
May 12, 2006
•
Rob Black
•
1 Comment